Quick answers
- What is Maxitrol?
- Maxitrol is a brand name of Neomycin sulfate, polymyxin b sulfate and dexamethasone, a prescription medicine. The FDA NDC Directory lists 3 Maxitrol products in 2 strengths and forms.
- Who makes Maxitrol?
- Sandoz holds the FDA application for Maxitrol (NDA050023, approved June 6, 1963). 2 other companies (repackagers or distributors) also list Maxitrol products.
- Is there a generic or store brand of Maxitrol?
- Yes. The FDA NDC Directory lists 11 other products with the same active ingredients, strength and form as a Maxitrol product, 11 of them generic. Ask your pharmacist whether one is right for you.
- Has Maxitrol been recalled?
- No recall linked to Maxitrol products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Maxitrol is
Each Maxitrol product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Neomycin sulfate, polymyxin b sulfate and dexamethasone · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| dexamethasone 0.1% · neomycin sulfate 0.35% · polymyxin b sulfate 10000 USP units/g ointment (ophthalmic) | Maxitrol | 8 products, 7 companies | DailyMed |
| dexamethasone 1 mg/mL · neomycin sulfate 3.5 mg/mL · polymyxin b sulfate 10000 USP units/mL suspension (ophthalmic) | Maxitrol | 3 products, 3 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Neomycin sulfate, polymyxin b sulfate and dexamethasone →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
Companies that list Maxitrol
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Maxitrol products.
- Sandoz Inc1 product
- Harrow Eye, LLC1 product
- Novartis Pharmaceuticals Corporation1 product
Recalls
No recall linked to Maxitrol products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.